Cancer Clinicians' Views Regarding an App That Helps Patients With Cancer Meet Their Information Needs: Qualitative Interview Study.
education, medical
medical information exchange
mobile apps
mobile phone
smartphone
Journal
JMIR cancer
ISSN: 2369-1999
Titre abrégé: JMIR Cancer
Pays: Canada
ID NLM: 101666844
Informations de publication
Date de publication:
06 May 2021
06 May 2021
Historique:
received:
17
09
2020
accepted:
28
03
2021
revised:
27
03
2021
entrez:
6
5
2021
pubmed:
7
5
2021
medline:
7
5
2021
Statut:
epublish
Résumé
Many patients with cancer have unmet information needs during the course of the illness. Smart devices, such as smartphones and tablet computers, provide an opportunity to deliver information to patients remotely. We aim to develop an app intervention to help patients with cancer meet their illness-related information needs in noninpatient settings. In addition to the in-depth exploration of the issues faced by the target users of a potential intervention, it is important to gain an understanding of the context in which the intervention will be used and the potential influences on its adoption. As such, understanding the views of clinicians is key to the successful implementation of this type of app in practice. Additionally, clinicians have an awareness of their patients' needs and can provide further insight into the type of app and features that might be most beneficial. This study aims to explore cancer clinicians' views on this type of intervention and whether they would support the use of an app in cancer care. Specifically, the perceived acceptability of an app used in consultations, useful app features, the potential benefits and disadvantages of an app, and barriers to app use were explored. A total of 20 qualitative, semistructured interviews were conducted with 22 clinicians from urological, colorectal, breast, or gynecological cancer clinics across 2 hospitals in South Wales. The interviews were audio recorded, transcribed, and analyzed using thematic analysis. Clinicians felt that it would be acceptable for patients to use such an app in noninpatient settings, including during consultations. The benefits of this type of app were anticipated to be a more informed patient, an increased sense of control for patients, better doctor-patient communication, and a more efficient and effective consultation. In contrast, an increase in clinicians' workload and poorer communication in consultations, which depended on the included app features, were identified as potential disadvantages. The anticipated barriers to app use included patients' age and prior experience with smart technology, their access to smart devices, the confidentiality of information, and an avoidant coping approach to their condition. This study suggests that clinicians should support their patients in using an app to help them meet their information needs both at home and during consultations. This study highlights some of the potential barriers for this type of intervention in practice, which could be minimized during the intervention design process.
Sections du résumé
BACKGROUND
BACKGROUND
Many patients with cancer have unmet information needs during the course of the illness. Smart devices, such as smartphones and tablet computers, provide an opportunity to deliver information to patients remotely. We aim to develop an app intervention to help patients with cancer meet their illness-related information needs in noninpatient settings. In addition to the in-depth exploration of the issues faced by the target users of a potential intervention, it is important to gain an understanding of the context in which the intervention will be used and the potential influences on its adoption. As such, understanding the views of clinicians is key to the successful implementation of this type of app in practice. Additionally, clinicians have an awareness of their patients' needs and can provide further insight into the type of app and features that might be most beneficial.
OBJECTIVE
OBJECTIVE
This study aims to explore cancer clinicians' views on this type of intervention and whether they would support the use of an app in cancer care. Specifically, the perceived acceptability of an app used in consultations, useful app features, the potential benefits and disadvantages of an app, and barriers to app use were explored.
METHODS
METHODS
A total of 20 qualitative, semistructured interviews were conducted with 22 clinicians from urological, colorectal, breast, or gynecological cancer clinics across 2 hospitals in South Wales. The interviews were audio recorded, transcribed, and analyzed using thematic analysis.
RESULTS
RESULTS
Clinicians felt that it would be acceptable for patients to use such an app in noninpatient settings, including during consultations. The benefits of this type of app were anticipated to be a more informed patient, an increased sense of control for patients, better doctor-patient communication, and a more efficient and effective consultation. In contrast, an increase in clinicians' workload and poorer communication in consultations, which depended on the included app features, were identified as potential disadvantages. The anticipated barriers to app use included patients' age and prior experience with smart technology, their access to smart devices, the confidentiality of information, and an avoidant coping approach to their condition.
CONCLUSIONS
CONCLUSIONS
This study suggests that clinicians should support their patients in using an app to help them meet their information needs both at home and during consultations. This study highlights some of the potential barriers for this type of intervention in practice, which could be minimized during the intervention design process.
Identifiants
pubmed: 33955836
pii: v7i2e23671
doi: 10.2196/23671
pmc: PMC8138703
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e23671Subventions
Organisme : Medical Research Council
ID : MC_UU_00006/6
Pays : United Kingdom
Informations de copyright
©Rebecca Richards, Paul Kinnersley, Kate Brain, Fiona Wood. Originally published in JMIR Cancer (https://cancer.jmir.org), 06.05.2021.
Références
J Natl Cancer Inst. 2021 May 4;113(5):523-531
pubmed: 32525530
Am J Prev Med. 2016 Nov;51(5):843-851
pubmed: 27745684
J Med Internet Res. 2010 Nov 29;12(4):e55
pubmed: 21115435
Psychooncology. 2017 Nov;26(11):1741-1748
pubmed: 28024096
J Med Internet Res. 2012 Sep 27;14(5):e128
pubmed: 23017375
JMIR Mhealth Uhealth. 2018 Dec 14;6(12):e10026
pubmed: 30552082
CA Cancer J Clin. 2003 Nov-Dec;53(6):356-71
pubmed: 15224975
J Health Psychol. 2019 Aug;24(9):1201-1209
pubmed: 28810403
Patient Educ Couns. 2017 Jan;100(1):5-7
pubmed: 27432014
Collegian. 2010;17(2):47-50
pubmed: 20738055
J Med Internet Res. 2015 Jan 30;17(1):e30
pubmed: 25639757
J Med Internet Res. 2001 Apr-Jun;3(2):E15
pubmed: 11720957
Support Care Cancer. 2016 Aug;24(8):3609-22
pubmed: 27137214
Med Care Res Rev. 2002 Sep;59(3):293-318
pubmed: 12205830
Psychooncology. 2013 Mar;22(3):490-8
pubmed: 22307579
J Med Internet Res. 2013 Dec 23;15(12):e287
pubmed: 24366061
Patient Educ Couns. 2020 Jan;103(1):120-126
pubmed: 31474389
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
J Eval Clin Pract. 2015 Apr;21(2):175-9
pubmed: 25318648
Eur J Oncol Nurs. 2008 Sep;12(4):380-6
pubmed: 18539527
J Cancer Educ. 2016 Jun;31(2):348-57
pubmed: 25712202
J Health Soc Behav. 1985 Jun;26(2):81-101
pubmed: 4031436
Br J Cancer. 2001 Nov 2;85(9):1273-9
pubmed: 11720460
Prim Care Respir J. 2006 Aug;15(4):237-45
pubmed: 16843066
Cancer. 2008 Jul 15;113(2):225-37
pubmed: 18484592
J Cancer Surviv. 2016 Feb;10(1):62-70
pubmed: 25956402
BMJ Open. 2012 Aug 24;2(4):
pubmed: 22923627
BMJ Open. 2018 Mar 12;8(3):e019576
pubmed: 29530909
Eur J Cancer Care (Engl). 1996 Sep;5(3):132-8
pubmed: 9117045
Int J Palliat Nurs. 2008 Sep;14(9):426-31
pubmed: 19060793
J Cancer Educ. 2013 Mar;28(1):138-42
pubmed: 23275239
JMIR Mhealth Uhealth. 2019 Jul 31;7(7):e14187
pubmed: 31368446
Patient Educ Couns. 2012 Feb;86(2):252-8
pubmed: 21741195
Support Care Cancer. 2006 Jul;14(7):742-52
pubmed: 16525792